Cas:328233-20-1 spiro[cyclohexane-4,3′-furo[3,4-c]pyridine]-1,1′-dione manufacturer & supplier

We serve Chemical Name:spiro[cyclohexane-4,3′-furo[3,4-c]pyridine]-1,1′-dione CAS:328233-20-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

spiro[cyclohexane-4,3'-furo[3,4-c]pyridine]-1,1'-dione

Chemical Name:spiro[cyclohexane-4,3′-furo[3,4-c]pyridine]-1,1′-dione
CAS.NO:328233-20-1
Synonyms:spiro[6-azaisobenzofuran-1(3H),1′-cyclohexane]-3,4′-dione;1’H-spiro[cyclohexane-1,3′-furo[3,4-c]pyridine]-1′,4-dione;3H,4’H-spiro[6-aza-2-benzofuran-1,1′-cyclohexane]-3,4′-dione;1’H,4H-spiro[cyclohexane-1,3′-furo[3,4-c]pyridine]-1′,4-dione;Spiro[cyclohexane-1,3′(1’H)-furo[3,4-c]pyridine]-1′,4-dione
Molecular Formula:C12H11NO3
Molecular Weight:217.22100
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:478ºC at 760mmHg
Density:1.35g/cm3
Index of Refraction:1.598
PSA:56.26000
Exact Mass:217.07400
LogP:1.59040

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like spiro[6-azaisobenzofuran-1(3H),1′-cyclohexane]-3,4′-dione chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Spiro[cyclohexane-1,3′(1’H)-furo[3,4-c]pyridine]-1′,4-dione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1’H,4H-spiro[cyclohexane-1,3′-furo[3,4-c]pyridine]-1′,4-dione Use and application,1’H-spiro[cyclohexane-1,3′-furo[3,4-c]pyridine]-1′,4-dione technical grade,usp/ep/jp grade.


Related News: AbbVie and Johnson & Johnson already boast three FDA-approved regimens for Imbruvica in newly diagnosed chronic lymphocytic leukemia (CLL). Now, the pair aims to add another to the drug’s label, one that could shorten the time patients need to stay on treatment. spiro[cyclohexane-4,3′-furo[3,4-c]pyridine]-1,1′-dione manufacturer The Company��s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). spiro[cyclohexane-4,3′-furo[3,4-c]pyridine]-1,1′-dione supplier Beneficial drug raw materials refer to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs). They are mainly used to meet the needs of original multinational pharmaceutical companies and emerging biopharmaceutical companies for innovative drugs in clinical drug research, registration approval and commercialization sales , Which also contains advanced intermediates used in the manufacture of the drug substance that need to be regulated by regulatory authorities. spiro[cyclohexane-4,3′-furo[3,4-c]pyridine]-1,1′-dione vendor AbbVie and Johnson & Johnson already boast three FDA-approved regimens for Imbruvica in newly diagnosed chronic lymphocytic leukemia (CLL). Now, the pair aims to add another to the drug’s label, one that could shorten the time patients need to stay on treatment. spiro[cyclohexane-4,3′-furo[3,4-c]pyridine]-1,1′-dione factory An effective treatment for Alzheimer��s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally.